| Product Code: ETC7644953 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antithrombin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antithrombin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antithrombin Market - Industry Life Cycle |
3.4 Israel Antithrombin Market - Porter's Five Forces |
3.5 Israel Antithrombin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Israel Antithrombin Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Israel Antithrombin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Israel Antithrombin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing awareness about antithrombin therapies and their benefits |
4.2.3 Rising healthcare expenditure and investments in advanced medical treatments in Israel |
4.3 Market Restraints |
4.3.1 High costs associated with antithrombin therapies |
4.3.2 Stringent regulatory requirements for approval of antithrombin drugs in Israel |
5 Israel Antithrombin Market Trends |
6 Israel Antithrombin Market, By Types |
6.1 Israel Antithrombin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Antithrombin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Israel Antithrombin Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.4 Israel Antithrombin Market Revenues & Volume, By Research, 2021- 2031F |
6.1.5 Israel Antithrombin Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.6 Israel Antithrombin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Antithrombin Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Israel Antithrombin Market Revenues & Volume, By Human, 2021- 2031F |
6.2.3 Israel Antithrombin Market Revenues & Volume, By Goat Milk (Recombinant), 2021- 2031F |
6.2.4 Israel Antithrombin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Antithrombin Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Israel Antithrombin Market Revenues & Volume, By Lyophilized, 2021- 2031F |
6.3.3 Israel Antithrombin Market Revenues & Volume, By Liquid, 2021- 2031F |
7 Israel Antithrombin Market Import-Export Trade Statistics |
7.1 Israel Antithrombin Market Export to Major Countries |
7.2 Israel Antithrombin Market Imports from Major Countries |
8 Israel Antithrombin Market Key Performance Indicators |
8.1 Patient adherence rate to antithrombin therapy |
8.2 Number of clinical trials and research studies on antithrombin treatments in Israel |
8.3 Adoption rate of antithrombin therapies in hospitals and healthcare facilities |
9 Israel Antithrombin Market - Opportunity Assessment |
9.1 Israel Antithrombin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Israel Antithrombin Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Israel Antithrombin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Israel Antithrombin Market - Competitive Landscape |
10.1 Israel Antithrombin Market Revenue Share, By Companies, 2024 |
10.2 Israel Antithrombin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here